Subpart K
21 CFR Part 111 Subpart K (§§111.303–111.325) governs every laboratory operation in support of dietary-supplement manufacturing — whether the QC laboratory is in-house, attached to the contract manufacturer, or fully outsourced to a third-party contract lab. Subpart K covers laboratory facility, equipment qualification, personnel qualification, scientifically-valid methods (the single requirement most often cited), reference standards, sampling plans, stability programmes, and record retention. The Subpart K record set is one of the four 'binders' an FDA inspector will demand on day one of an inspection.
01What Subpart K covers
Part 111 Subpart K is the chapter inside which all laboratory activity supporting supplement manufacturing must operate. The scope is broad: any test, measurement, or examination required by Subparts E (component testing), F (QC operations), H (production), I (manufacturing records), J (records), or L (packaging) must be performed under Subpart K controls — including identity testing, finished-product specification testing, microbiological testing, stability testing, environmental monitoring, and water testing.
02Subpart K section by section
| Section | Requirement | Common inspection ask |
|---|---|---|
| §111.303 | Must use lab facilities, methods, equipment and personnel as required | Show me your lab manual / SOPs |
| §111.310 | Adequate laboratory facility for the tests performed | Walk-through of the lab; HVAC and segregation |
| §111.315 | Laboratory equipment that is calibrated, maintained, and used appropriately | Calibration records for every instrument; out-of-cal log |
| §111.320 | Scientifically valid methods — verified or validated for the matrix | Method validation packs; verification records |
| §111.325 | Reserve samples must be tested when investigating consumer complaints or other quality issues | Reserve-sample log; pulled-for-investigation records |
Subpart K is mercifully short (just five sections) — but each section unpacks into substantial operational scope. The framework is consistent with USP <1058>, ISO/IEC 17025, and the broader cGMP analytical-laboratory expectations from Part 211 (drug) and Part 117 (food).
03§111.310 — Laboratory facility
The facility section is brief but inspectors interpret it strictly: dedicated laboratory space (not shared with production), appropriate environmental controls (temperature and humidity for analytical work, balances on vibration-damped surfaces, fume-hood ventilation, UV-protected storage for light-sensitive reagents), segregation of incompatible operations (microbiology vs chemistry, sterile vs non-sterile work), and adequate sample-storage segregation (incoming vs in-process vs finished vs retain vs stability). Shared lab/production benches are a frequent inspection citation.
04§111.315 — Equipment calibration and qualification
Every analytical instrument that contributes to a release decision must be calibrated and maintained. The defensible programme follows USP <1058> Analytical Instrument Qualification, which defines four risk tiers:
| Tier | Examples | Qualification depth |
|---|---|---|
| A — Standard equipment, no measurement chain | Vortex mixers, magnetic stirrers, ovens (non-critical) | Verify on receipt; periodic maintenance only |
| B — Standard equipment with measurement | Balances, pH meters, refractometers, ovens (critical) | Calibration on receipt + scheduled; written procedure |
| C — Computerised analytical instruments with discrete operating procedures | HPLC, GC, FTIR, dissolution apparatus, ICP-MS | Full IQ/OQ/PQ; periodic re-qualification; CSV |
| D — Specialised / custom-configured instruments | Custom-built test rigs, in-house-developed measurement systems | Full IQ/OQ/PQ + bespoke validation |
For Category C instruments (the bulk of supplement-lab equipment), the qualification cycle is: IQ (installation qualification — instrument arrived as specified), OQ (operational qualification — instrument operates within manufacturer's specifications), PQ (performance qualification — instrument performs the intended analytical use case acceptably), then ongoing calibration verification on a defined cadence (typically daily for system suitability, monthly for in-depth calibration, annual for re-qualification).
05Personnel qualification — the implicit Subpart K requirement
Subpart K does not have a dedicated personnel section, but personnel qualification is implicit throughout (§111.303 cites 'personnel as required' and Subpart B at §111.12 + §111.14 sets education / training / experience requirements). Defensible programmes treat lab analysts as a separately-qualified personnel category with:
- Position-specific job description listing methods qualified to perform.
- Documented initial training + competency demonstration before independent work.
- Annual re-training on cGMP, data-integrity, and any new methods added to scope.
- Per-method competency record — analyst is qualified to perform Method X for Matrix Y; not blanket-qualified across all lab work.
- Continuing-education record for technique- or instrument-specific updates.
06Outsourced laboratory — same rules apply
Many small to mid-sized supplement manufacturers outsource all or part of their lab work to contract laboratories. Subpart K obligations do NOT transfer to the contract lab — the manufacturer remains responsible for Part 111 compliance, including ensuring that the contract lab operates under equivalent controls. Defensible outsourced-lab management requires:
- Documented qualification of the lab (on-site audit or, at minimum, document review including ISO 17025 or AOAC accreditation, FDA inspection history, and recent CAPA history).
- Quality agreement governing scope of work, method selection, deviation reporting, OOS investigation, sample retention, and record access.
- Method-by-method qualification — the manufacturer confirms each method is fit for purpose on their specific matrix.
- Periodic re-qualification (at minimum annual) of the lab as a supplier under Subpart B.
- OOS results communicated to the manufacturer's QC unit, which retains disposition authority — the contract lab does not 'release' product.
07Common Subpart K Warning Letter failure modes
- §111.320 — using a published method (USP, AOAC) without verifying it on the specific matrix; failure to validate any in-house-developed method.
- §111.315 — calibration overdue; instrument used past calibration expiry; no out-of-tolerance investigation when calibration found drifted.
- §111.325 — reserve sample destroyed before completion of complaint investigation that required it.
- §111.310 — analytical balance located on a production-shared bench; pH meter calibration buffer expired; HPLC mobile-phase prep area shared with microbiology work.
- Outsourced lab not qualified — contract sent based on price quote without supplier qualification record.
- OOS results 'investigated' by the analyst who ran the original test rather than independent reviewer — Subpart F + Subpart K crossover.
- Data-integrity gap — chromatography data not retained as the raw electronic record; only the printed report kept.
- Method changed (column brand, sample prep) without re-qualification; results compared to old acceptance criteria.
08How V5 Ultimate handles Subpart K
- Instrument register tagged by USP <1058> tier with calibration cadence + lockout interlock on overdue.
- Method library with validation / verification record linkage; method cannot be used in LIMS until linkage present.
- Per-analyst per-method qualification record; analyst cannot be assigned a method outside their qualified scope.
- Reserve-sample disposition workflow with complaint / investigation cross-reference (§111.325 linkage).
- OOS workflow with auto-routing to independent reviewer; original analyst blocked from signing the investigation.
- Contract-lab supplier qualification module with annual re-qualification + per-method scope.
- Raw chromatography file retention linkage on every result (data-integrity).
- Calibration audit-trail with as-found / as-left values surfacing out-of-tolerance investigation when triggered.
Frequently asked questions
Q.Does Subpart K apply if I outsource all lab work?+
Yes — you (the manufacturer) remain responsible for Part 111 compliance, including ensuring the contract lab operates under equivalent controls. You must qualify the lab as a supplier and own the disposition decision.
Q.What is the difference between method validation and method verification?+
Validation establishes that a method works (typically for in-house developed methods); verification confirms an established compendial method (USP, AOAC) works on your specific matrix. Both are explicitly permitted under §111.320 — but you must document one or the other for every method in use.
Q.Do I need ISO 17025 accreditation?+
Not federally — but ISO 17025 is the consensus standard for laboratory competence, and using an accredited contract lab dramatically reduces your supplier-qualification burden. Many in-house supplement labs operate under ISO 17025 principles without formal accreditation.
Q.How often must instruments be calibrated?+
Defined by your written procedure and the manufacturer's specification. Typical cadences: daily system suitability for chromatography; monthly multi-point calibration verification; annual full re-qualification.
Q.What happens when an instrument is found out-of-calibration?+
All results since the last successful calibration must be reviewed for impact; any release decision made on those results is potentially compromised. This is the trigger for a §111.260 deviation investigation.
Q.Can production share an analytical balance with QC?+
Generally no — shared facility / equipment use between production and QC is a frequent inspection citation under §111.310 because of contamination and uncontrolled-environment risk.
Q.Who can sign off on an OOS investigation?+
An independent reviewer — not the analyst who ran the original test. Subpart F's QC-unit independence requirement applies.
Primary sources
- 21 CFR Part 111 Subpart K — Laboratory Operations (§§111.303–111.325)
- 21 CFR 111.320 — Scientifically valid method requirement
- ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories
- FDA Guidance — Validation of Bioanalytical Methods (May 2018) — cited by analogy in supplement-method validation
- USP General Chapter <1058> Analytical Instrument Qualification
- FDA — Dietary Supplement Warning Letters (filter Subpart K citations)
Further reading
- Scientifically valid method (111.320)The single most-cited section of Subpart K.
- Identity testing (111.75)The Subpart E rule Subpart K supports.
- Microbial limits (supplements)Microbiological methods sit inside Subpart K.
- Heavy metals (supplements)ICP-MS methods sit inside Subpart K.
- Reserve sample (111.83)Cross-reference; Subpart K covers reserve-sample lab handling.
V5 Ultimate ships with the Subpart K controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.